Baird analyst Brian Skorney lifted his price target on Outperform-rated Gilead Sciences (NASDAQ: GILD) to $135.00 (from $126.00) following earnings ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Gilead Sciences' (GILD) Price Target Bumped to $135 at Deutsche BankJuly 29, 2015 10:13 AM Gilead Sciences (GILD) PT Raised to $134 at Piper Jaffray on Another 'Beat and Raise'July 29, 2015 9:10 AM Gilead Sciences (GILD) PT Raised to $120 at Oppenheimer on Solid Q2 BeatJuly 29, 2015 6:28 AM Gilead Sciences (GILD) Tops Q2 EPS by 44cJuly 28, 2015 4:02 PM Gilead Sciences Announces Third Quarter 2015 DividendJuly 28, 2015 4:02 PM Gilead Sciences Announces Second Quarter 2015 Financial ResultsJuly 28, 2015 4:01 PM